Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 3, 2010, Pages

  Teodosio, Cristina ^a   García Montero, Andrés C ^a   Jara Acevedo, María ^a   Sánchez Muñoz, Laura ^b   Álvarez Twose, Ivan ^b   Núñez, Rosa ^c   Schwartz, Lawrence B ^d   Walls, Andrew F ^e   Escribano, Luis ^b   Orfao, Alberto ^a  

^a Centro de Investigacion del Cancer   (Spain)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL CLONING; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPHENOTYPING; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MAST CELL; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC MASTOCYTOSIS;

EID: 77949268924     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.10.020     Document Type: Article

References (42)

1. Valent P., Horny H.P., Escribano L., Longley B.J., Li C.Y., Schwartz L.B., et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 25 (2001) 603-625
2. Sperr W.R., Escribano L., Jordan J.H., Schernthaner G.H., Kundi M., Horny H.P., et al. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res 25 (2001) 529-536
3. Stevens E.C., and Rosenthal N.S. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease. Hematopathology 116 (2001) 117-182
4. Samorapoompichit P., Schernthaner G.H., Worda C., Wimazal F., Krauth M.T., Sperr W.R., et al. Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy. Histopathology 48 (2006) 247-257
5. Schernthaner G.H., Jordan J.H., Ghannadan M., Agis H., Bevec D., Nuñez R., et al. Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells. Blood 98 (2001) 3784-3792
6. Escribano L., García-Montero A., Nuñez R., and Orfao A. Flow cytometric analysis of normal and neoplastic mast cells: role in diagnosis and follow-up of mast cell disease. Immunol Allergy Clin North Am 26 (2006) 535-547
7. Escribano L., Orfao A., Díaz-Agustin B., Villarrubia J., Cerveró C., López A., et al. Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood 91 (1998) 2731-2736
8. Valent P., Horny H.-P., Li C.Y., Longley J.B., Metcalfe D.D., Parwaresch R.M., et al. Mastocytosis (mast cell disease). In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization (WHO) classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon, France p. 291-302
9. Escribano L., Orfao A., Díaz Agustín B., Cerveró C., Herrero S., Villarrubia J., et al. Human bone marrow mast cells from indolent systemic mast cell disease constitutively express increased amounts of the CD63 protein on their surface. Cytometry 34 (1998) 223-228
10. Díaz-Agustín B., Escribano L., Bravo P., Herrero S., Nuñez R., Navalón R., et al. The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease. Br J Haematol 106 (1999) 400-405
11. Escribano L., Díaz-Agustín B., Núñez R., Prados A., Rodríguez R., and Orfao A. Abnormal expression of CD antigens in mastocytosis. Int Arch Allergy Immunol 127 (2002) 127-132
12. Núñez-López R., Escribano L., Schernthaner G.H., Prados A., Rodríguez-González R., Díaz-Agustín B., et al. Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis. Br J Haematol 120 (2003) 257-265
13. Orfao A., Garcia-Montero A.C., Sanchez L., and Escribano L. Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br J Haematol 138 (2007) 12-30
14. Garcia-Montero A.C., Jara-Acevedo M., Teodosio C., Sanchez M.L., Nuñez R., Prados A., et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 108 (2006) 2366-2372
15. Horny H.P., Sotlar K., and Valent P. Mastocytosis: state of the art. Pathobiology 74 (2007) 121-132
16. Akin C., Fumo G., Yavuz A.S., Lipsky P.E., Neckers L., and Metcalfe D.D. A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 103 (2004) 3222-3225
17. Akin C., Escribano L., Núñez R., García-Montero A., Angulo M., Orfao A., et al. Well-differentiated systemic mastocytosis: a new disease variant with mature mast cell phenotype and lack of codon 816 c-Kit mutations. [abstract]. J Allergy Clin Immunol 113 Suppl 2 (2004) S327
18. Bonadonna P., Perbellini O., Passalacqua G., Caruso B., Colarossi S., Dal Fior D., et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 123 (2009) 680-686
19. Akin C., Scott L.M., Kocabas C.N., Kushnir-Sukhov N., Brittain E., Noel P., et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. Blood 110 (2007) 2331-2333
20. Guo X., Schrader K.A., Xu Y., and Schrader J.W. Expression of a constitutively active mutant of M-Ras in normal bone marrow is sufficient for induction of a malignant mastocytosis/mast cell leukemia, distinct from the histiocytosis/monocytic leukemia induced by expression of activated H-Ras. Oncogene 24 (2005) 2330-2342
21. Guo X., Stratton L., and Schrader J.W. Expression of activated M-Ras in hemopoietic stem cells initiates leukemogenic transformation, immortalization and preferential generation of mast cells. Oncogene 25 (2006) 4241-4244
22. De Zen L., Orfao A., Cazzaniga G., Masiero L., Cocito M.G., Spinelli M., et al. Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype, I: ETV6/AML1 ALLs identification. Leukemia 14 (2000) 1225-1231
23. Tabernero M.D., Bortoluci A.M., Alaejos I., López-Berges M.C., Rasillo A., García-Sanz R., et al. Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression. Leukemia 15 (2001) 406-414
24. Orfao A., Chillón M.C., Bortoluci A.M., López-Berges M.C., García-Sanz R., Gonzalez M., et al. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements. Haematologica 84 (1999) 405-412
25. Pardanani A., Kimlinger T., Reeder T., Li C.-Y., and Tefferi A. Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients. Leuk Res 28 (2004) 777-783
26. Cerveró C., Escribano L., San Miguel J.F., Díaz-Agustín B., Bravo P., Villarrubia J., et al. Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia. Am J Hematol 60 (1999) 191-195
27. Escribano L., Alvarez-Twose I., Sánchez-Muñoz L., Garcia-Montero A., Núñez R., Almeida J., et al. Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol 124 (2009) 514-521
28. Sotlar K., Escribano L., Landt O., Möhrle S., Herrero S., Torrelo A., et al. One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol 162 (2003) 737-746
29. Escribano L., Díaz-Agustín B., Bellas C., Navalón R., Nuñez R., Sperr W.R., et al. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis. Leuk Res 25 (2001) 563-570
30. Woolhiser M.R., Okayama Y., Gilfillan A.M., and Metcalfe D.D. IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma. Eur J Immunol 31 (2001) 3298-3307
31. Marshall J.S. Mast-cell responses to pathogens. Nat Rev Immunol 4 (2004) 787-799
32. Henz B.M., Maurer M., Lippert U., Worm M., and Babina M. Mast cells as initiators of immunity and host defense. Exp Dermatol 10 (2001) 1-10
33. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 6 (2005) 135-142
34. Stelekati E., Orinska Z., and Bulfone-Paus S. Mast cells in allergy: innate instructors of adaptive responses. Immunobiology 212 (2007) 505-519
35. Orfao A., Escribano L., Villarrubia J., Velasco J.L., Cerveró C., Ciudad J., et al. Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration. Am J Pathol 149 (1996) 1493-1499
36. Alfredsson J., Puthalakath H., Martin H., Strasser A., and Nilsson G. Proapoptotic Bcl-2 family member Bim is involved in the control of mast cell survival and is induced together with Bcl-XL upon IgE-receptor activation. Cell Death Differ 12 (2005) 136-144
37. Hartmann K., Artuc M., Baldus S.E., Zirbes T.K., Hermes B., Thiele J., et al. Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis. Am J Pathol 163 (Suppl 2) (2003) 819-826
38. Schwartz L.B., Min H.K., Ren S., Xia H.Z., Hu J., Zhao W., et al. Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells. J Immunol 170 (2003) 5667-5673
39. Schernthaner G.H., Hauswirth A.W., Baghestanian M., Agis H., Ghannadan M., Worda C., et al. Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors. Allergy 60 (2005) 1248-1255
40. Matarraz S., López A., Barrena S., Fernandez C., Jensen E., Flores J., et al. The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors. Leukemia 22 (2008) 1175-1183
41. Rottem M., Okada T., Goff J.P., and Metcalfe D.D. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population. Blood 84 (1994) 2489-2496
42. Okayama Y., and Kawakami T. Development, migration, and survival of mast cells. Immunol Res 34 (2006) 97-115